Menu
Search for
Log In
Topics
AI & Technology
Agentic
Analytics
Automation
Blockchain
Cloud
Computer Vision
Conversational AI
Cyber Security
Data
Digital Transformation
Ethics & Responsibility
Future of AI
IoT
Machine Learning
Metaverse
Natural Language Processing (NLP)
Responsible AI
Robotics
Sectors & Use Cases
Automotive
Education
Energy
Finance
Gaming
Healthcare
Insurance
Manufacturing
Property & Real Estate
Public Sector
Retail
Sports
Supply Chain & Logistics
Telecommunications
AI Business Strategy
Digital Transformation
Environment & Sustainability
Ethics & Responsibility
HR, Workforce, and Skills
Legal & Compliance
Marketing & Customer
Product & Revenue
Policy & Regulation
AI Leadership & Perspective
Boardroom & Governance
C-Suite Perspective
Community Voices
Founder & Investor Voices
Innovation Spotlight
Interview
Leadership Vision
Strategic Partnerships
Columnists
The Control Layer By Victor Dey
Learn
Events
Newsletter
Reports & Guides
Webinars
Media Kit
Premium
Login
Contact Us
Search for
Home
/
Press release
Press release
Press Release
Cision PR Newswire
30 March 2026
Leidos completes $2.4 billion acquisition of ENTRUST
Read More »
Press Release
Cision PR Newswire
30 March 2026
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
Read More »
Press Release
Cision PR Newswire
30 March 2026
Search Homes and See What You Can Afford with the New Realtor.com® App in ChatGPT
Read More »
Press Release
Cision PR Newswire
30 March 2026
Leidos completes $2.4 billion acquisition of ENTRUST
Read More »
Press Release
Cision PR Newswire
30 March 2026
From Experience to Trust: KuCoin Connects Crypto with Culture at Tomorrowland Winter
Read More »
Press Release
Cision PR Newswire
30 March 2026
Search Homes and See What You Can Afford with the New Realtor.com® App in ChatGPT
Read More »
Press Release
Cision PR Newswire
30 March 2026
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
Read More »
Cision PR Newswire
30 March 2026
Huawei Receives Frost & Sullivan’s 2025 Global Technology Innovation Leadership Recognition in Telecom DC Power
Read More »
Press Release
Cision PR Newswire
30 March 2026
Ekinops signs a Memorandum of Understanding with a tier-1 European telecom operator for the deployment of a large scale optical network
Read More »
Press Release
Cision PR Newswire
30 March 2026
J&T Express Reports 18.5% YoY Revenue Growth for FY2025; New Markets Achieve Full-Year Profitability for the First Time
Read More »
Previous page
Next page
Back to top button
Close
Search for
Close
Search for
Close
Log In
Forget?
Remember me
Log In
